Results 11 to 20 of about 16,017 (247)

Physiologically based biopharmaceutics modeling of regional and colon absorption in humans [PDF]

open access: yes, 2023
Colon absorption is a key determinant for successful development of extended release and colon targeted drug products. This is the first systematic evaluation of the ability to predict in vivo regional differences in absorption and the extent of colon ...
Jadhav, Harshad   +16 more
core   +1 more source

Shared IVIVR for Five Commercial Enabling Formulations Using the BiPHa+ Biphasic Dissolution Assay

open access: yesPharmaceutics, 2021
The present study intended to confirm the in vivo relevance of the BiPHa+ biphasic dissolution assay using a single set of assay parameters. Herein, we evaluated five commercial drug products formulated by various enabling formulation principles under ...
Alexander Denninger   +2 more
doaj   +1 more source

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

open access: yesPharmaceutics, 2021
The encapsulation of therapeutic agents into nano-based drug delivery system for cancer treatment has received considerable attention in recent years. Advancements in nanotechnology provide an opportunity for efficient delivery of anticancer drugs.
Lu Tang   +5 more
doaj   +1 more source

Diammonium Glycyrrhizinate-Based Micelles for Improving the Hepatoprotective Effect of Baicalin: Characterization and Biopharmaceutical Study

open access: yesPharmaceutics, 2022
Saponins are an important class of surface-active substances. When formulated as an active ingredient or co-used with other drugs, the effect of their surface activity on efficacy or safety must be considered.
Xingxing Dai   +11 more
doaj   +1 more source

Method development for quantification of DMET-proteins in the paediatric intestinal tract via LC-MS/MS using a QconCAT technique

open access: yesBritish Journal of Pharmacy, 2022
Physiologically based pharmacokinetic (PBPK) modelling is a powerful alternative for paediatric clinical trials. Paediatric PBPK models require data on intestinal drug metabolising enzymes and transporter (DMET)-protein abundances, however only limited ...
Jan Goelen   +2 more
doaj   +1 more source

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP [PDF]

open access: yes, 2020
The application of in silico modeling to predict the in vivo outcome of an oral drug product is gaining a lot of interest. Fully relying on these models as a surrogate tool requires continuous optimization and validation.
Dickens, Joseph   +17 more
core   +1 more source

Subcutaneous Biopharmaceutics: Building tools for a flexible future

open access: yesBritish Journal of Pharmacy, 2023
The major biopharmaceutics challenge faced during the development of subcutaneous (SC) drug products is the limited understanding of the physiological factors and the combination product attributes that can impact absorption rate/extent and drug product ...
Kate Louise Harris   +4 more
doaj   +1 more source

Understanding the Impact of Age-Related Changes in Pediatric GI Solubility by Multivariate Data Analysis

open access: yesPharmaceutics, 2022
The aim of this study was to understand drug solubilization as a function of age and identify drugs at risk of altered drug solubility in newborns and young infants in comparison to adults.
Mariana Guimarães   +4 more
doaj   +1 more source

New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain

open access: yesFrontiers in Endocrinology, 2022
Reducing injection-site pain (ISP) in patients with chronic conditions such as growth hormone deficiency is a valuable strategy to improve patient compliance and therapeutic efficiency.
Bita Taghizadeh   +4 more
doaj   +1 more source

Microneedle-Mediated Transdermal Delivery of Genetic Materials, Stem Cells, and Secretome: An Update and Progression

open access: yesPharmaceutics, 2023
Medical practitioners commonly use oral and parenteral dosage forms to administer drugs to patients. However, these forms have certain drawbacks, particularly concerning patients’ comfort and compliance.
Avelia Devina Calista Nainggolan   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy